DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume-Reference-Cited by-同舟云学术

DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

Published:2013-03-05 Issue:1 Volume:8 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Wurstbauer Karl,Deutschmann Heinz,Dagn Karin,Kopp Peter,Zehentmayr Franz,Lamprecht Bernd,Porsch Peter,Wegleitner Birgit,Studnicka Michael,Sedlmayer Felix

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-8-49.pdf

Reference31 articles.

1. Curran WJ, Paulus R, Langer C, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD: Sequential vs. concurrent chemoradiation for stage III non-small lung cancer: Randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011, 103: 1452-1460. 10.1093/jnci/djr325

2. Cox JD: Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 2012, 82: 1042-1044. 10.1016/j.ijrobp.2011.12.032

3. Kong FM, Randall K, Ten Haken RK, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA: High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small cell lung cancer: Long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63: 324-333. 10.1016/j.ijrobp.2005.02.010

4. Fowler J: Biological factors influencing optimum fractionation in radiation therapy. Acta oncol 2001, 40: 712-717. 10.1080/02841860152619124

5. Mauguen A, Le Péchoux C, Saunders M, Schild S, Turrisi A, Baumann M, Sause W, Ball D, Belanie C, Bonner J, Zajusz A, Dahlberg S, Nankivell M, Mandrekar S, Paulus R, Behrendt K, Koch R, Bishop J, Dische S, Arriagada R, De Ruysscher D, Pignon JP: Hyperfractionated or accelerated radiotherapy in lung cancer: An individual patient data meta-anlysis. J Clin Oncol 2012, 30: 2788-2797. 10.1200/JCO.2012.41.6677

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate;Cancers;2023-03-25

2. Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT;Radiation Oncology;2022-07-07

3. Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Retrospective Comparison Focusing on Pulmonary Toxicity;Cancers;2022-06-30

4. Complete pathological response in locally advanced non-small-cell lung cancer patient: A case report;World Journal of Clinical Cases;2021-07-16

5. Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis;Current Oncology;2021-05-13